324 related articles for article (PubMed ID: 27417698)
1. Biochanin A Protects Against Lipopolysaccharide-Induced Damage of Dopaminergic Neurons Both In Vivo and In Vitro via Inhibition of Microglial Activation.
Wang J; Wu WY; Huang H; Li WZ; Chen HQ; Yin YY
Neurotox Res; 2016 Oct; 30(3):486-98. PubMed ID: 27417698
[TBL] [Abstract][Full Text] [Related]
2. Biochanin A protects against angiotensin II-induced damage of dopaminergic neurons in rats associated with the increased endophilin A2 expression.
Xue HX; Kong H; Yu YG; Zhou JW; Chen HQ; Yin YY
Behav Pharmacol; 2019 Dec; 30(8):700-711. PubMed ID: 31703032
[TBL] [Abstract][Full Text] [Related]
3. Biochanin A protects dopaminergic neurons against lipopolysaccharide-induced damage and oxidative stress in a rat model of Parkinson's disease.
Wang J; He C; Wu WY; Chen F; Wu YY; Li WZ; Chen HQ; Yin YY
Pharmacol Biochem Behav; 2015 Nov; 138():96-103. PubMed ID: 26394281
[TBL] [Abstract][Full Text] [Related]
4. Biochanin A protects dopaminergic neurons against lipopolysaccharide-induced damage through inhibition of microglia activation and proinflammatory factors generation.
Chen HQ; Jin ZY; Li GH
Neurosci Lett; 2007 May; 417(2):112-7. PubMed ID: 17399896
[TBL] [Abstract][Full Text] [Related]
5. Biochanin A attenuates LPS-induced pro-inflammatory responses and inhibits the activation of the MAPK pathway in BV2 microglial cells.
Wu WY; Wu YY; Huang H; He C; Li WZ; Wang HL; Chen HQ; Yin YY
Int J Mol Med; 2015 Feb; 35(2):391-8. PubMed ID: 25483920
[TBL] [Abstract][Full Text] [Related]
6. α-Asarone attenuates microglia-mediated neuroinflammation by inhibiting NF kappa B activation and mitigates MPTP-induced behavioral deficits in a mouse model of Parkinson's disease.
Kim BW; Koppula S; Kumar H; Park JY; Kim IW; More SV; Kim IS; Han SD; Kim SK; Yoon SH; Choi DK
Neuropharmacology; 2015 Oct; 97():46-57. PubMed ID: 25983275
[TBL] [Abstract][Full Text] [Related]
7. Galangin Reduces the Loss of Dopaminergic Neurons in an LPS-Evoked Model of Parkinson's Disease in Rats.
Chen G; Liu J; Jiang L; Ran X; He D; Li Y; Huang B; Wang W; Fu S
Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29267220
[TBL] [Abstract][Full Text] [Related]
8. Vanillin Protects Dopaminergic Neurons against Inflammation-Mediated Cell Death by Inhibiting ERK1/2, P38 and the NF-κB Signaling Pathway.
Yan X; Liu DF; Zhang XY; Liu D; Xu SY; Chen GX; Huang BX; Ren WZ; Wang W; Fu SP; Liu JX
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28208679
[TBL] [Abstract][Full Text] [Related]
9. Somatostatin prevents lipopolysaccharide-induced neurodegeneration in the rat substantia nigra by inhibiting the activation of microglia.
Bai L; Zhang X; Li X; Liu N; Lou F; Ma H; Luo X; Ren Y
Mol Med Rep; 2015 Jul; 12(1):1002-8. PubMed ID: 25777539
[TBL] [Abstract][Full Text] [Related]
10. Glucocorticoid receptor is involved in the neuroprotective effect of ginsenoside Rg1 against inflammation-induced dopaminergic neuronal degeneration in substantia nigra.
Sun XC; Ren XF; Chen L; Gao XQ; Xie JX; Chen WF
J Steroid Biochem Mol Biol; 2016 Jan; 155(Pt A):94-103. PubMed ID: 26455404
[TBL] [Abstract][Full Text] [Related]
11. Curcumin protects dopaminergic neurons against inflammation-mediated damage and improves motor dysfunction induced by single intranigral lipopolysaccharide injection.
Sharma N; Sharma S; Nehru B
Inflammopharmacology; 2017 Jun; 25(3):351-368. PubMed ID: 28409389
[TBL] [Abstract][Full Text] [Related]
12. n-3 polyunsaturated fatty acids inhibit lipopolysaccharide-induced microglial activation and dopaminergic injury in rats.
Ji A; Diao H; Wang X; Yang R; Zhang J; Luo W; Cao R; Cao Z; Wang F; Cai T
Neurotoxicology; 2012 Aug; 33(4):780-8. PubMed ID: 22406923
[TBL] [Abstract][Full Text] [Related]
13. Farrerol protects dopaminergic neurons in a rat model of lipopolysaccharide-induced Parkinson's disease by suppressing the activation of the AKT and NF-κB signaling pathways.
Li Y; Zeng Y; Meng T; Gao X; Huang B; He D; Ran X; Du J; Zhang Y; Fu S; Hu G
Int Immunopharmacol; 2019 Oct; 75():105739. PubMed ID: 31351366
[TBL] [Abstract][Full Text] [Related]
14. Tenuigenin protects dopaminergic neurons from inflammation via suppressing NLRP3 inflammasome activation in microglia.
Fan Z; Liang Z; Yang H; Pan Y; Zheng Y; Wang X
J Neuroinflammation; 2017 Dec; 14(1):256. PubMed ID: 29262843
[TBL] [Abstract][Full Text] [Related]
15. GPER and IGF-1R mediate the anti-inflammatory effect of genistein against lipopolysaccharide (LPS)-induced nigrostriatal injury in rats.
Du ZR; Gu Y; Xie XM; Zhang M; Jiang GY; Chen WF
J Steroid Biochem Mol Biol; 2021 Nov; 214():105989. PubMed ID: 34478828
[TBL] [Abstract][Full Text] [Related]
16. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
[TBL] [Abstract][Full Text] [Related]
17. 2-Acetyl-7-hydroxy-6-methoxy-1-methyl-1,2,3,4,-tetrahydroisoquinoline exhibits anti-inflammatory properties and protects the nigral dopaminergic neurons.
Son HJ; Han SH; Lee JA; Lee CS; Seo JW; Chi DY; Hwang O
Eur J Pharmacol; 2016 Jan; 771():152-61. PubMed ID: 26687634
[TBL] [Abstract][Full Text] [Related]
18. IL-17A exacerbates neuroinflammation and neurodegeneration by activating microglia in rodent models of Parkinson's disease.
Liu Z; Qiu AW; Huang Y; Yang Y; Chen JN; Gu TT; Cao BB; Qiu YH; Peng YP
Brain Behav Immun; 2019 Oct; 81():630-645. PubMed ID: 31351185
[TBL] [Abstract][Full Text] [Related]
19. Potential repositioning of exemestane as a neuroprotective agent for Parkinson's disease.
Son HJ; Han SH; Lee JA; Shin EJ; Hwang O
Free Radic Res; 2017 Jun; 51(6):633-645. PubMed ID: 28770670
[TBL] [Abstract][Full Text] [Related]
20. Erinacine A Prevents Lipopolysaccharide-Mediated Glial Cell Activation to Protect Dopaminergic Neurons against Inflammatory Factor-Induced Cell Death In Vitro and In Vivo.
Lee SL; Hsu JY; Chen TC; Huang CC; Wu TY; Chin TY
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054997
[No Abstract] [Full Text] [Related]
[Next] [New Search]
